Subacute oral toxicity study of bisphenol F based on the draft protocol for the “Enhanced OECD Test Guideline no. 407”
N Higashihara, K Shiraishi, K Miyata, Y Oshima… - Archives of …, 2007 - Springer
Abstract Since bisphenol F (4, 4'-dihydroxydiphenylmethane) has been reported to exhibit
estrogen agonistic properties in the uterotrophic assay, we performed a 28-day repeated …
estrogen agonistic properties in the uterotrophic assay, we performed a 28-day repeated …
Subacute oral toxicity study of bisphenol F based on the draft protocol for the" Enhanced OECD Test Guideline no. 407"
N Higashihara, K Shiraishi, K Miyata… - Archives of …, 2007 - search.proquest.com
Abstract Since bisphenol F (4, 4'-dihydroxydiphenylmethane) has been reported to exhibit
estrogen agonistic properties in the uterotrophic assay, we performed a 28-day repeated …
estrogen agonistic properties in the uterotrophic assay, we performed a 28-day repeated …
[引用][C] Subacute oral toxicity study of bisphenol F based on the draft protocol for the Enhanced OECD Test Guideline no. 407
N HIGASHIHARA, K SHIRAISHI, K MIYATA… - Archives of …, 2007 - pascal-francis.inist.fr
Subacute oral toxicity study of bisphenol F based on the draft protocol for the Enhanced
OECD Test Guideline no. 407 CNRS Inist Pascal-Francis CNRS Pascal and Francis …
OECD Test Guideline no. 407 CNRS Inist Pascal-Francis CNRS Pascal and Francis …
Subacute oral toxicity study of bisphenol F based on the draft protocol for the “Enhanced OECD Test Guideline no. 407”
N Higashihara, K Shiraishi, K Miyata, Y Oshima… - Archives of …, 2007 - infona.pl
Since bisphenol F (4, 4'-dihydroxydiphenylmethane) has been reported to exhibit estrogen
agonistic properties in the uterotrophic assay, we performed a 28-day repeated-dose toxicity …
agonistic properties in the uterotrophic assay, we performed a 28-day repeated-dose toxicity …
Subacute oral toxicity study of bisphenol F based on the draft protocol for the" Enhanced OECD Test Guideline no. 407".
N Higashihara, K Shiraishi, K Miyata… - Archives of …, 2007 - europepmc.org
Since bisphenol F (4, 4'-dihydroxydiphenylmethane) has been reported to exhibit estrogen
agonistic properties in the uterotrophic assay, we performed a 28-day repeated-dose toxicity …
agonistic properties in the uterotrophic assay, we performed a 28-day repeated-dose toxicity …
Subacute oral toxicity study of bisphenol F based on the draft protocol for the “Enhanced OECD Test Guideline no. 407”.
N Higashihara, K Shiraishi, K Miyata… - Archives of …, 2007 - search.ebscohost.com
Abstract Since bisphenol F (4, 4'-dihydroxydiphenylmethane) has been reported to exhibit
estrogen agonistic properties in the uterotrophic assay, we performed a 28-day repeated …
estrogen agonistic properties in the uterotrophic assay, we performed a 28-day repeated …
Subacute oral toxicity study of bisphenol F based on the draft protocol for the" Enhanced OECD Test Guideline no. 407"
N Higashihara, K Shiraishi, K Miyata… - Archives of …, 2007 - pubmed.ncbi.nlm.nih.gov
Since bisphenol F (4, 4'-dihydroxydiphenylmethane) has been reported to exhibit estrogen
agonistic properties in the uterotrophic assay, we performed a 28-day repeated-dose toxicity …
agonistic properties in the uterotrophic assay, we performed a 28-day repeated-dose toxicity …
Subacute oral toxicity study of bisphenol F based on the draft protocol for the “Enhanced OECD Test Guideline no. 407”.
N Higashihara, K Shiraishi, K Miyata… - Archives of …, 2007 - search.ebscohost.com
Abstract Since bisphenol F (4, 4'-dihydroxydiphenylmethane) has been reported to exhibit
estrogen agonistic properties in the uterotrophic assay, we performed a 28-day repeated …
estrogen agonistic properties in the uterotrophic assay, we performed a 28-day repeated …